OKUR OnKure Therapeutics, Inc. - Class A Common Stock
OKUR Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
OKUR Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
OKUR Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
- Güçlü Al 4 33,3%
- Al 6 50,0%
- Tut 2 16,7%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
4 analist · 2026-08-18Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 30 Haziran 2026 | $-0.31 | $-0.55 | 0.24% |
| 31 Mart 2026 | $-1.11 | $-0.76 | -0.35% |
| 31 Aralık 2025 | $-0.99 | $-1.18 | 0.18% |
| 30 Eylül 2025 | $-1.09 | $-1.22 | 0.13% |
| 30 Haziran 2025 | $-1.14 | $-1.27 | 0.13% |
| 31 Mart 2025 | $-1.19 | $-1.49 | 0.30% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| OKUR | — | -0.7 | — | -1733.7% | -88.6% | — |
| VYGR | $232M | -1.9 | -49.5% | -296.5% | -54.4% | — |
| CHRS | $172M | 1.0 | 59.8% | 398.4% | 185.8% | — |
| NKTX | $131M | -1.3 | — | — | -31.1% | — |
| CRBU | $151M | -1.0 | 11.7% | -1327.4% | -102.8% | — |
| CNTB | $159M | -2.8 | -99.8% | -86687.5% | -97.9% | — |
| TNYA | $154M | -1.2 | — | — | -81.2% | — |
| CNTN | $112M | -2.7 | — | — | -18.0% | — |
| HUMA | — | — | — | — | — | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 13
| Metrik | Eğilim | 2025 | 2024 |
|---|---|---|---|
| Revenue | · | $0 | |
| R&D Expense | $48M | $44M | |
| SG&A Expense | $15M | $11M | |
| Operating Expenses | $63M | $54M | |
| Operating Income | $-63M | $-54M | |
| Interest Income | $3M | $2M | |
| Income Tax | $0 | $0 | |
| Net Income | $-60M | $-53M | |
| EPS (Basic) | $-4.40 | $-15.28 | |
| EPS (Diluted) | $-4.40 | $-15.28 | |
| Shares (Basic) | 13,515,915 | 3,447,071 | |
| Shares (Diluted) | 13,515,915 | 3,447,071 | |
| EBITDA | $-63M | $-54M |
Bilanço 19
| Metrik | Eğilim | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $59M | $111M | |
| Prepaid Expense | $2M | $2M | |
| Current Assets | $61M | $113M | |
| PP&E (Net) | $618.0K | $1M | |
| PP&E (Gross) | $2M | $2M | |
| Accum. Depreciation | $1M | $1M | |
| Other Non-current Assets | $273.0K | $109.0K | |
| Total Assets | $62M | $115M | |
| Accounts Payable | $1M | $3M | |
| Accrued Liabilities | · | $7M | |
| Current Liabilities | $6M | $11M | |
| Capital Leases | $0 | $549.0K | |
| Other Non-current Liabilities | $12.0K | · | |
| Total Liabilities | $6M | $11M | |
| Paid-in Capital | $270M | $259M | |
| Retained Earnings | $-214M | $-155M | |
| AOCI | $0 | · | |
| Stockholders' Equity | $56M | $104M | |
| Liabilities + Equity | $62M | $115M |
Nakit Akışı 9
| Metrik | Eğilim | 2025 | 2024 |
|---|---|---|---|
| D&A | $447.0K | $459.0K | |
| Stock-based Comp | $12M | $5M | |
| Other Non-cash | $-4M | $-3M | |
| Operating Cash Flow | $-52M | $-51M | |
| CapEx | $46.0K | $52.0K | |
| Investing Cash Flow | $-46.0K | $16M | |
| Financing Cash Flow | $163.0K | $116M | |
| Net Change in Cash | $-52M | $81M | |
| Free Cash Flow | $-52M | $-51M |
Kârlılık 5
| Metrik | Eğilim | 2025 | 2024 |
|---|---|---|---|
| Operating Margin | -1833.7% | · | |
| Net Margin | -1733.7% | · | |
| EBITDA Margin | -1820.6% | · | |
| ROA | -67.2% | -69.9% | |
| ROE | -88.6% | 337.4% |
Likidite ve Solventlik 2
| Metrik | Eğilim | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 10.3 | 10.7 | |
| Quick Ratio | 10.0 | 10.5 |
Verimlilik 1
| Metrik | Eğilim | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 |
Değerleme (TTM) 4
| Metrik | Eğilim | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | · | $0 | |
| Net Income TTM | $-60M | $-53M | |
| P/E | -0.7 | -0.6 | |
| Earnings Yield | -151.7% | -177.7% |
Gelir Tablosu 12
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $13M | $12M | $11M | $12M | $13M | $13M | $14M | $10M | $11M | $9M | $-7M | $14M | $14M | $11M | $10M | $10M | |
| SG&A Expense | $4M | $4M | $3M | $4M | $4M | $4M | $4M | $1M | $4M | $1M | $-14M | $7M | $7M | $5M | $4M | $4M | |
| Operating Expenses | $17M | $16M | $14M | $16M | $16M | $17M | $19M | $12M | $14M | $10M | $-21M | $21M | $21M | $16M | $15M | $14M | |
| Operating Income | $-17M | $-16M | $-14M | $-16M | $-16M | $-17M | $-19M | $-12M | $-14M | $-10M | $21M | $-21M | $-21M | $-16M | $-15M | $-14M | |
| Interest Income | $2M | $458.0K | $628.0K | $804.0K | $934.0K | $1M | $1M | $174.0K | $230.0K | $295.0K | · | · | · | · | · | · | |
| Other Non-op | · | · | · | · | · | · | · | $972.0K | $1M | $1M | · | $2M | $2M | $1M | $962.0K | $833.0K | |
| Net Income | $-15M | $-15M | $-14M | $-15M | $-15M | $-16M | $-17M | $-12M | $-14M | $-10M | $19M | $-19M | $-20M | $-15M | $-14M | $-13M | |
| EPS (Basic) | $-0.31 | $-1.11 | $-0.98 | $-1.09 | $-1.14 | $-1.19 | $96.46 | $-36.55 | $-44.82 | $-30.37 | $-117.48 | $-5.68 | $-0.65 | $-0.60 | $-0.56 | $-0.53 | |
| EPS (Diluted) | $-0.31 | $-1.11 | $-0.98 | $-1.09 | $-1.14 | $-1.19 | $96.46 | $-36.55 | $-44.82 | $-30.37 | $-117.48 | $-5.68 | $-0.65 | $-0.60 | $-0.56 | $-0.53 | |
| Shares (Basic) | 49,869,177 | 13,674,577 | -26,948,392 | 13,530,892 | 13,509,080 | 13,424,335 | 2,501,435 | 316,142 | 315,478 | 314,016 | -58,348,708 | 3,380,794 | 30,215,321 | 25,036,410 | -48,922,002 | 24,496,313 | |
| Shares (Diluted) | 49,869,177 | 13,674,577 | -26,948,392 | 13,530,892 | 13,509,080 | 13,424,335 | 2,501,435 | 316,142 | 315,478 | 314,016 | -58,348,708 | 3,380,794 | 30,215,321 | 25,036,410 | -48,922,002 | 24,496,313 | |
| EBITDA | $-17M | $-16M | · | $-15M | $-16M | $-17M | · | $-5M | $-6M | $-10M | · | $-21M | $-21M | $-16M | · | $-14M |
Bilanço 22
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $167M | $192M | $59M | $70M | $83M | $97M | $111M | $61M | $36M | $20M | $30M | $12M | $9M | $30M | $20M | $62M | |
| Short-term Investments | · | · | · | · | · | · | · | $16M | $41M | $62M | · | $114M | $134M | $63M | $81M | $54M | |
| Prepaid Expense | $1M | $5M | $2M | $1M | $1M | $2M | $2M | $331.0K | $1M | $1M | $4M | $3M | $4M | $3M | $5M | $5M | |
| Current Assets | $178M | $197M | $61M | $72M | $85M | $98M | $113M | $77M | $78M | $84M | $34M | $129M | $146M | $97M | $106M | $121M | |
| PP&E (Net) | $435.0K | $519.0K | $618.0K | $720.0K | $821.0K | $925.0K | $1M | $59.0K | $81.0K | $102.0K | $1M | $529.0K | $554.0K | $581.0K | $453.0K | $241.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | · | · | $2M | · | · | · | $555.0K | · | |
| Accum. Depreciation | $2M | $2M | $1M | $1M | $1M | $1M | $1M | · | · | · | $665.0K | · | · | · | $102.0K | · | |
| Other Non-current Assets | $401.0K | $405.0K | $273.0K | $104.0K | $116.0K | $109.0K | $109.0K | $147.0K | $153.0K | $64.0K | $58.0K | $81.0K | $79.0K | $81.0K | $84.0K | $79.0K | |
| Total Assets | $179M | $199M | $62M | $73M | $86M | $100M | $115M | $78M | $79M | $85M | $36M | $130M | $148M | $99M | $108M | $123M | |
| Accounts Payable | $2M | $11M | $1M | $1M | $2M | $2M | $3M | $237.0K | $64.0K | $676.0K | $3M | $2M | $2M | $2M | $2M | $2M | |
| Accrued Liabilities | · | · | · | · | $5M | $6M | · | $725.0K | $953.0K | $2M | $4M | $11M | $12M | $8M | $5M | $7M | |
| Current Liabilities | $7M | $14M | $6M | $6M | $8M | $9M | $11M | $3M | $1M | $3M | $7M | $14M | $14M | $10M | $7M | $9M | |
| Capital Leases | $590.0K | $0 | · | $120.0K | $267.0K | $409.0K | $549.0K | $379.0K | $492.0K | $576.0K | $466.0K | $812.0K | $897.0K | $979.0K | $1M | $943.0K | |
| Other Non-current Liabilities | $12.0K | $12.0K | $12.0K | $40.0K | $40.0K | $40.0K | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $7M | $14M | $6M | $6M | $8M | $9M | $11M | $4M | $2M | $3M | $8M | $15M | $16M | $12M | $8M | $10M | |
| Common Stock | · | · | · | · | · | · | · | $0 | $3.0K | $3.0K | · | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | |
| Paid-in Capital | $417M | $414M | $270M | $267M | $264M | $261M | $259M | $310M | $309M | $308M | $209.0K | $305M | $304M | $239M | $237M | $235M | |
| Retained Earnings | $-245M | $-229M | $-214M | $-201M | $-186M | $-171M | $-155M | $-236M | $-232M | $-227M | $-102M | $-191M | $-171M | $-152M | $-137M | $-123M | |
| AOCI | $-13.0K | · | · | · | · | · | · | $2.0K | $-13.0K | $-12.0K | · | $-21.0K | $-31.0K | $12.0K | $-43.0K | $-26.0K | |
| Stockholders' Equity | $172M | $184M | $56M | $66M | $78M | $91M | $104M | $74M | $77M | $81M | $-102M | $115M | $133M | $87M | $100M | $112M | |
| Liabilities + Equity | $179M | $199M | $62M | $73M | $86M | $100M | $115M | $78M | $79M | $85M | $36M | $130M | $148M | $99M | $108M | $123M | |
| Shares Outstanding | · | · | · | · | · | · | · | 3,343,525 | 33,420,808 | 33,420,808 | · | 33,872,166 | 33,800,788 | 25,107,430 | 24,699,553 | 24,529,646 |
Nakit Akışı 11
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $87.0K | $104.0K | $104.0K | $108.0K | $117.0K | $118.0K | $116.0K | $114.0K | $115.0K | $114.0K | $291.0K | $43.0K | $42.0K | $41.0K | $25.0K | $22.0K | |
| Stock-based Comp | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $-70.0K | $842.0K | $107.0K | $-4M | $1M | $1M | $1M | $1M | $990.0K | |
| Other Non-cash | · | $-665.0K | · | · | · | $-943.0K | · | · | · | $-14M | · | · | · | $5M | · | · | |
| Operating Cash Flow | $-10M | $-13M | $-12M | $-13M | $-13M | $-14M | $-23M | $58.0K | $4M | $-11M | $9M | $-19M | $-16M | $-9M | $-16M | $-11M | |
| CapEx | $3.0K | $5.0K | $9.0K | $6.0K | $13.0K | $18.0K | $15.0K | $35.0K | $10.0K | $9.0K | $50.0K | $19.0K | $5.0K | $172.0K | $250.0K | $28.0K | |
| Investing Cash Flow | $-10M | $-5.0K | $-9.0K | $-6.0K | $-13.0K | $-18.0K | $16M | $-36M | $-14M | $-9.0K | $29M | $21M | $-69M | $19M | $-27M | $-45M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $1M | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $1M | · | · | |
| Financing Cash Flow | $-5M | $146M | $240.0K | $0 | $0 | $-77.0K | $110M | $6M | $6M | $10.0K | $-12M | $173.0K | $64M | $1M | $325.0K | $97.0K | |
| Net Change in Cash | $-26M | $133M | $-11M | $-13M | $-13M | $-14M | $103M | $-30M | $-4M | $-11M | $27M | $3M | $-21M | $10M | $-42M | $-56M | |
| Free Cash Flow | · | $-13M | · | · | · | $-14M | · | · | · | · | · | · | · | $-9M | · | · |
Kârlılık 5
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1088.2% | -3409.4% | · | -1932.8% | -1747.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -988.2% | -3309.4% | · | -1832.8% | -1647.8% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1088.2% | -3386.7% | · | -1919.3% | -1735.2% | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -11.6% | -10.2% | · | -19.5% | -18.7% | -17.3% | · | -3.5% | -4.7% | -9.2% | · | -15.2% | -13.9% | -12.4% | · | -9.1% | |
| ROE | -12.3% | -11.0% | · | -20.9% | -19.9% | -18.5% | · | -3.9% | -5.1% | -10.0% | · | -16.9% | -15.2% | -13.6% | · | -9.7% |
Likidite ve Solventlik 2
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 26.7 | 13.8 | · | 11.4 | 11.1 | 11.2 | · | 23.7 | 57.9 | 29.8 | · | 9.5 | 10.7 | 9.3 | · | 12.8 | |
| Quick Ratio | 25.1 | 13.4 | · | 11.3 | 11.0 | 11.0 | · | 23.6 | 56.9 | 29.4 | · | 9.3 | 10.4 | 8.9 | · | 12.3 |
Verimlilik 1
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM) 8
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-59M | $-59M | · | $-63M | $-60M | $-59M | · | $-54M | $-62M | $-63M | · | $-67M | $-60M | $-53M | · | $-51M | |
| Market Cap | · | · | · | · | · | · | · | $57M | $505M | $555M | · | $2.58B | $2.22B | $1.50B | · | $822M | |
| P/E | -1.2 | -0.9 | · | -0.1 | -0.0 | -0.0 | · | -0.1 | -0.2 | -0.4 | · | -10.2 | -28.8 | -27.7 | · | -16.1 | |
| P/B | · | · | · | · | · | · | · | 0.8 | 6.6 | 6.8 | · | 22.4 | 16.7 | 17.2 | · | 7.3 | |
| P / Tangible Book | · | · | · | · | · | · | · | 0.8 | 6.6 | 6.8 | · | 22.4 | 16.7 | 17.2 | · | 7.3 | |
| P / Cash Flow | · | · | · | · | · | · | · | · | · | -26.4 | · | · | · | -165.9 | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | -162.8 | · | · | |
| Earnings Yield | -80.0% | -109.4% | · | -1453.5% | -3502.1% | -2626.3% | · | -690.7% | -539.9% | -224.7% | · | -9.8% | -3.5% | -3.6% | · | -6.2% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | — | $0 | — | — | — |
| Faaliyet Kâr Marjı % | -1833.7% | — | — | — | — |
| Net Gelir | $-60M | $-53M | $-35M | $-52M | $-40M |
| Seyreltilmiş Hisse Başı Kâr | $-4.40 | $-15.28 | $-124.41 | $-2.12 | $-2.19 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Cari Oran | 10.3 | 10.7 | — | 14.9 | 24.8 |
| Cari Oran | 10.0 | 10.5 | — | 14.2 | 23.8 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-52M | $-51M | — | $-48M | $-38M |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 78 dosya · $148.9M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 34 (+19 önceki Ç'ye göre) | 7 (0 önceki Ç'ye göre) | 14 (+1 önceki Ç'ye göre) | 13 (+1 önceki Ç'ye göre) | +3.3M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $18.232.398 | 3.998.333 | 12,25% | Hisse senetleri |
| BVF INC/IL | $14.755.148 | 3.235.778 | 9,91% | Hisse senetleri |
| ACORN CAPITAL ADVISORS, LLC | $12.948.913 | 2.839.674 | 8,70% | Hisse senetleri |
| StepStone Group LP | $11.014.934 | 2.660.612 | 7,40% | Hisse senetleri |
| ADAR1 Capital Management, LLC | $10.208.399 | 2.238.684 | 6,86% | Hisse senetleri |
| Vivo Capital, LLC | $8.790.358 | 1.927.710 | 5,91% | Hisse senetleri |
| Vestal Point Capital, LP | $8.325.187 | 1.825.699 | 5,59% | Hisse senetleri |
| Trails Edge Capital Partners, LP | $6.559.359 | 1.438.456 | 4,41% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $6.552.898 | 1.437.039 | 4,40% | Hisse senetleri |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $5.493.975 | 1.204.819 | 3,69% | Hisse senetleri |
| CITADEL ADVISORS LLC | $5.412.934 | 1.187.047 | 3,64% | Hisse senetleri |
| Sio Capital Management, LLC | $4.920.080 | 1.078.965 | 3,31% | Hisse senetleri |
| Prosight Management, LP | $4.464.204 | 978.992 | 3,00% | Hisse senetleri |
| Logos Global Management LP | $4.395.179 | 963.855 | 2,95% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $2.788.902 | 611.596 | 1,87% | Hisse senetleri |
| NEA Management Company, LLC | $2.182.179 | 478.548 | 1,47% | Hisse senetleri |
| STATE STREET CORP | $2.114.299 | 463.662 | 1,42% | Hisse senetleri |
| Ensign Peak Advisors, Inc | $1.968.237 | 431.631 | 1,32% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $1.635.845 | 358.738 | 1,10% | Hisse senetleri |
| Sofinnova Investments, Inc. | $1.466.916 | 321.692 | 0,99% | Hisse senetleri |
| Carlyle Group Inc. | $1.230.721 | 269.895 | 0,83% | Hisse senetleri |
| Seven Fleet Capital Management LP | $1.098.791 | 240.963 | 0,74% | Hisse senetleri |
| Affinity Asset Advisors, LLC | $1.098.791 | 240.963 | 0,74% | Hisse senetleri |
| DV EQUITIES, LLC | $1.098.791 | 240.963 | 0,74% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $810.613 | 177.766 | 0,54% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $753.207 | 165.177 | 0,51% | Hisse senetleri |
| Rosalind Advisors, Inc. | $684.000 | 150.000 | 0,46% | Hisse senetleri |
| Stonepine Capital Management, LLC | $595.919 | 130.684 | 0,40% | Hisse senetleri |
| KOTLER KEVIN | $573.304 | 197.691 | 0,39% | Hisse senetleri |
| Longaeva Partners L.P. | $549.398 | 120.482 | 0,37% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $496.447 | 108.870 | 0,33% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $484.819 | 106.320 | 0,33% | Hisse senetleri |
| CANTOR FITZGERALD, L. P. | $456.064 | 100.014 | 0,31% | Hisse senetleri |
| UBS Group AG | $454.194 | 99.604 | 0,31% | Hisse senetleri |
| Rangeley Capital, LLC | $433.200 | 95.000 | 0,29% | Hisse senetleri |
| Aisling Capital Management LP | $404.048 | 88.607 | 0,27% | Hisse senetleri |
| Walleye Capital LLC | $324.230 | 71.103 | 0,22% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $290.198 | 63.640 | 0,19% | Hisse senetleri |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $229.336 | 50.293 | 0,15% | Hisse senetleri |
| Shay Capital LLC | $228.000 | 50.000 | 0,15% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $221.766 | 48.633 | 0,15% | Hisse senetleri |
| PRELUDE CAPITAL MANAGEMENT, LLC | $212.916 | 46.692 | 0,14% | Hisse senetleri |
| Aldebaran Capital, LLC | $181.803 | 39.869 | 0,12% | Hisse senetleri |
| Nuveen, LLC | $161.433 | 35.402 | 0,11% | Hisse senetleri |
| Verdad Advisers, LP | $130.690 | 28.660 | 0,09% | Hisse senetleri |
| Bank of New York Mellon Corp | $119.705 | 26.251 | 0,08% | Hisse senetleri |
| DEUTSCHE BANK AG\ | $116.572 | 25.564 | 0,08% | Hisse senetleri |
| AMERICAN CENTURY COMPANIES INC | $105.231 | 23.077 | 0,07% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $100.097 | 21.951 | 0,07% | Hisse senetleri |
| RHUMBLINE ADVISERS | $95.736 | 20.996 | 0,06% | Hisse senetleri |
| Jump Financial, LLC | $93.024 | 20.400 | 0,06% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $90.694 | 19.889 | 0,06% | Hisse senetleri |
| MARSHALL WACE, LLP | $83.744 | 18.365 | 0,06% | Hisse senetleri |
| NEW YORK STATE COMMON RETIREMENT FUND | $82.536 | 18.100 | 0,06% | Hisse senetleri |
| XTX Topco Ltd | $77.383 | 16.970 | 0,05% | Hisse senetleri |
| TWO SIGMA ADVISERS, LP | $77.163 | 26.608 | 0,05% | Hisse senetleri |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $55.035 | 12.069 | 0,04% | Hisse senetleri |
| Y-Intercept (Hong Kong) Ltd | $51.473 | 11.288 | 0,03% | Hisse senetleri |
| CITIGROUP INC | $48.687 | 10.677 | 0,03% | Hisse senetleri |
| Invesco Ltd. | $47.657 | 10.451 | 0,03% | Hisse senetleri |
| Police & Firemen's Retirement System of New Jersey | $47.073 | 10.323 | 0,03% | Hisse senetleri |
| MORGAN STANLEY | $29.900 | 6.557 | 0,02% | Hisse senetleri |
| BARCLAYS PLC | $20.520 | 4.500 | 0,01% | Hisse senetleri |
| NORTHERN TRUST CORP | $18.778 | 4.118 | 0,01% | Hisse senetleri |
| Legal & General Group Plc | $11.651 | 2.555 | 0,01% | Hisse senetleri |
| Ameritas Investment Partners, Inc. | $10.848 | 2.379 | 0,01% | Hisse senetleri |
| Russell Investments Group, Ltd. | $9.557 | 2.096 | 0,01% | Hisse senetleri |
| Tower Research Capital LLC (TRC) | $7.346 | 1.611 | 0,00% | Hisse senetleri |
| BlackRock, Inc. | $6.644 | 1.457 | 0,00% | Hisse senetleri |
| ROYAL BANK OF CANADA | $4.000 | 966 | 0,00% | Hisse senetleri |
| Sterling Capital Management LLC | $2.408 | 528 | 0,00% | Hisse senetleri |
| VANGUARD GROUP INC | $2.161 | 745 | 0,00% | Hisse senetleri |
| TRUST CO OF TOLEDO NA /OH/ | $620 | 136 | 0,00% | Hisse senetleri |
| OSAIC HOLDINGS, INC. | $410 | 90 | 0,00% | Hisse senetleri |
| FMR LLC | $406 | 89 | 0,00% | Hisse senetleri |
| JPMORGAN CHASE & CO | $203 | 45 | 0,00% | Hisse senetleri |
| PRICE T ROWE ASSOCIATES INC /MD/ | $98 | 21.481 | 0,00% | Hisse senetleri |
| T. Rowe Price Investment Management, Inc. | $70 | 15.335 | 0,00% | Hisse senetleri |
Şirket yöneticileri 28 içeriden öğrenenler · 6 yöneticiler · 9 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Gregory J. Flesher | President and CEO | 09 Aralık 2022 A | 109.600 | 0 | 0 | $0 |
| Michael Cruse | Chief Operating Officer | 09 Aralık 2022 A | 13.697 | 0 | 0 | $0 |
| Ashley Hall | Chief Development Officer | 28 Ağustos 2023 M | 39.600 | 0 | 0 | $0 |
| Jennifer Lam | VP of Finance & Administration | 09 Aralık 2022 A | — | 0 | 0 | $0 |
| Alejandro Dorenbaum | Chief Medical Officer | 09 Aralık 2022 A | 30.000 | 0 | 0 | $0 |
| Wendy S. Johnson | Chief Development Officer | 14 Temmuz 2021 S | 0 | 0 | 0 | $0 |
| Roshawn A. Blunt | Yönetim kurulu üyesi | 06 Haziran 2023 A | — | 0 | 0 | $0 |
| Bali Muralidhar | Yönetim kurulu üyesi | 06 Haziran 2023 A | 2.073.957 | 0 | 0 | $0 |
| Niall O'Donnell, Ph.D. | Yönetim kurulu üyesi | 06 Haziran 2023 A | 2.188.713 | 0 | 0 | $0 |
| Eric M Dube | Yönetim kurulu üyesi | 06 Haziran 2023 A | — | 0 | 0 | $0 |
| Stacey Denenberg Seltzer | Yönetim kurulu üyesi | 06 Haziran 2023 A | — | 0 | 0 | $0 |
| Paul W. Hoelscher | Yönetim kurulu üyesi | 06 Haziran 2023 A | — | 0 | 0 | $0 |
| Lon Cardon | Yönetim kurulu üyesi | 08 Nisan 2021 A | — | 0 | 0 | $0 |
| Kenneth Harrison Ph.D. | Yönetim kurulu üyesi | 08 Nisan 2021 A | — | 0 | 0 | $0 |
| Novo Holdings A/S | 10% sahip | 23 Haziran 2023 S | 3.330.337 | 0 | 0 | $0 |
| Dylan Hartley | — | 07 Ağustos 2026 A | — | 0 | 0 | $0 |
| Andrew John Phillips | — | 07 Ağustos 2026 A | — | 0 | 0 | $0 |
| Valerie Malyvanh Jansen | — | 07 Ağustos 2026 A | — | 0 | 0 | $0 |
| Samuel Agresta | — | 07 Ağustos 2026 A | — | 0 | 0 | $0 |
| Jason A. Leverone | — | 07 Ağustos 2026 A | 18.802 | 0 | 1 | $-1.333 |
| Michael R Carruthers | — | 07 Ağustos 2026 A | — | 0 | 0 | $0 |
| Isaac Manke | — | 07 Ağustos 2026 A | — | 0 | 0 | $0 |
| Nicholas A Saccomano | — | 07 Ağustos 2026 A | 11.247 | 0 | 1 | $-378 |
| Liam Ratcliffe | — | 07 Ağustos 2026 A | — | 0 | 0 | $0 |
| Edward T. Mathers | — | 07 Ağustos 2026 A | 15.310 | 0 | 0 | $0 |
| Michael G Grey | — | 07 Ağustos 2026 A | 0 | 0 | 0 | $0 |
| Leonard Braden Michael | — | 07 Ekim 2024 J | 102.076 | 0 | 0 | $0 |
| Vineet R. Jindal | — | 10 Aralık 2021 A | 36.600 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 10 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| AI Biotechnology LLC, Access Industries Holdings LLC, Access Industries Management, LLC, Len Blavatnik | 07 Nisan 2026 | 19,99% | İlk başvuru | — | SEC |
| ACORN BIOVENTURES, L.P., ACORN CAPITAL ADVISORS GP, LLC, Anders Hove, ACORN BIOVENTURES 2, L.P., Acorn Capital Advisors GP 2, LLC ×2 başvurular | 30 Mayıs 2025 | 22,10% | Değişiklik | — | SEC |
| RiverVest Venture Fund III, L.P., RiverVest Venture Fund III (Ohio), L.P., RiverVest Venture Partners III (Ohio), LLC, RiverVest Venture Partners III, L.P., RiverVest Venture Partners III, LLC, RiverVest Venture Fund IV, L.P., RiverVest Venture Partners IV, L.P., RiverVest Venture Partners IV, LLC, John P. McKearn, Ph.D., Jay Schmelter, Thomas C. Melzer, Niall O'Donnell, Ph.D. | 21 Ocak 2025 | 1,55% | Değişiklik | — | SEC |
| 08 Ekim 2024 | — | İlk başvuru | — | SEC | |
| New Enterprise Associates 15, L.P., NEA Partners 15, L.P., NEA 15 GP, LLC, Forest Baskett, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell ×2 başvurular | 08 Mayıs 2024 | — | İlk başvuru | — | SEC |
| TANG CAPITAL PARTNERS, LP, TANG CAPITAL MANAGEMENT, LLC, KEVIN TANG, Concentra Biosciences, LLC | 26 Aralık 2023 | — | İlk başvuru | — | SEC |
| Novo Holdings A/S ×5 başvurular | 15 Aralık 2023 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 30 Mayıs 2023 | — | İlk başvuru | — | SEC |
| Abingworth LLP, Abingworth Bioventures 8, LP | 20 Nisan 2021 | — | İlk başvuru | Pasif yatırım | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 19 Nisan 2021 | — | İlk başvuru | Pasif yatırım | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 5 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| IWC · iShares Trust | 0,02% | 87.541 SH | 08 Ağustos 2026 | Günlük |
| IWN · iShares Trust | 0,01% | 225.561 SH | 08 Ağustos 2026 | Günlük |
| IWM · iShares Trust | 0,00% | 557.532 SH | 08 Ağustos 2026 | Günlük |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 8.831 NS | 31 Mayıs 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 21.147 NS | 30 Nisan 2026 | N-PORT |